09:50 AM EST - Acerus Pharmaceuticals Corporation : Has entered into an amending agreement with First Generation Capital Inc., a company affiliated with the Chairman of the Board of Directors of Acerus, to increase its existing secured loan facility from $35.845 million U.S. to $37.945 million U.S. This increase was made available to the Company by way of a single advance of $2.1 million U.S. on June 23, under a secured grid promissory note with First Generation. Acerus Pharmaceuticals Corporation
shares T.ASP are trading unchanged at $3.00.
